EyePoint (EYPT) Work In Process (2018 - 2026)

EyePoint (EYPT) reported Work In Process of $84000.0 for Q1 2026, down 75.22% on a YoY basis from $339000.0 in Q1 2025, and down 85.62% sequentially from $584000.0 in Q4 2025.

EyePoint (EYPT) Work In Process (2018 - 2026) Analysis & Trends

EyePoint (EYPT) has 9 years of Work In Process data on file, last reported at $84000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Work In Process fell 75.22% year-over-year to $84000.0; the trailing twelve-month figure through Mar 2026 stood at $84000.0 (down 75.22% YoY), and the FY2025 full-year result was $584000.0, down 9.88% from the prior year.
  • Work In Process declined to $84000.0 in Q1 2026, from $584000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.9 million in Q3 2023 to a low of $84000.0 in Q1 2026.
  • A 5-year average of $869529.4 and a median of $854000.0 in 2022 frame the typical range for Work In Process.
  • Across the five-year window, Work In Process jumped 288.89% in 2022 and sank 75.22% in 2026, its largest moves.
  • Tracing EYPT's Work In Process over 5 years: stood at $1.1 million in 2022, then retreated by 18.18% to $882000.0 in 2023, then dropped by 26.53% to $648000.0 in 2024, then slipped by 9.88% to $584000.0 in 2025, then tumbled by 85.62% to $84000.0 in 2026.
  • Business Quant data shows EYPT's Work In Process at $84000.0 in Q1 2026, $584000.0 in Q4 2025, and $498000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 84,000.00
Dec 31, 2025 584,000.00
Sep 30, 2025 498,000.00
Jun 30, 2025 1.00 Mn
Mar 31, 2025 339,000.00
Dec 31, 2024 648,000.00
Sep 30, 2024 649,000.00
Jun 30, 2024 921,000.00
Mar 31, 2024 1.09 Mn
Dec 31, 2023 882,000.00
Sep 30, 2023 1.86 Mn
Jun 30, 2023 1.43 Mn
Mar 31, 2023 1.60 Mn
Dec 31, 2022 1.08 Mn
Sep 30, 2022 854,000.00
Jun 30, 2022 595,000.00
Mar 31, 2022 671,000.00
Dec 31, 2021 405,000.00
Sep 30, 2021 571,000.00
Jun 30, 2021 153,000.00